Company
ICON Public Limited Company
Headquarters: Dublin, Ireland
Founded: 1990
Employees: 38,330
CEO: Dr. Steven A. Cutler
Market Cap
$16.73 Billion
USD as of Jan. 1, 2025
ICON Public Limited Company Categories
Ireland Healthcare Diagnostics & ResearchIreland Healthcare Ireland Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $8.31 B |
| EBITDA | $1.67 B |
| Gross Profit TTM | $2.46 B |
| Profit Margin | 9.00% |
| Operating Margin | 14.45% |
| Quarterly Revenue Growth | -1.20% |
Stocks & Indices
ICON Public Limited Company has the following listings and related stock indices.
Stock: NASDAQ: ICLR wb_incandescent
Stock: FSX: IJF wb_incandescent
Product & Services
Services for pharmaceutical, biotech and medical device industries
Key People
Founder(s): John Climax, Co-founder, Ronan Lambe, Co-founder
Steve Cutler, CEO